Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like Akers Biosciences Reports Preliminary Unaudited Earnings Highlights For Fiscal Year 2016 March 30, 2017 Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections March 25, 2018 Biogen Release: Company Reports 2016 Revenues Of $11.4 Billion January 25, 2017
Akers Biosciences Reports Preliminary Unaudited Earnings Highlights For Fiscal Year 2016 March 30, 2017